• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconBristol Myers Squibb

Bristol Myers Squibb

Bristol Myers Squibb CEO Chris Boerner says company culture was the missing piece of his ‘patent cliff’ plan
C-Suite
Bristol Myers Squibb CEO Chris Boerner says company culture was the missing piece of his ‘patent cliff’ plan
By Diane BradyDecember 5, 2025
Cancer vaccination, conceptual illustration
Health
Personalized vaccine offers hope for patients with late-stage kidney cancer, clinical trial shows
By Lindsey LeakeFebruary 7, 2025
A researcher examining a slide while standing with coworker in background at laboratory
Health
20 innovative breakthroughs that will transform your health
By Erika FryDecember 18, 2024
Developing new medicines for everyone, everywhere, equally
Commentary
Developing new medicines for everyone, everywhere, equally
By Giovanni Caforio, MDNovember 13, 2023
Board members in discussion at conference table in office
Newsletters
Here’s what differentiates the top 25 corporate boards from their counterparts
By Lila MacLellanMay 12, 2023
François Locoh-Donou, CEO of F5 sits on a chair in his living room
Leadership
These 25 companies have the most ‘modern’ boards. Here’s what that means
By Lila MacLellanMay 10, 2023
Bristol-Myers Squibb logo on a smartphone
Newsletters
What a Bristol-Myers project to monitor off-label prescribing says about future uses of A.I.
By Jeremy Kahn and Jonathan VanianJanuary 25, 2022
Leaders from Peloton, Chobani, and more on how brands earn their purpose
Conferences
Leaders from Peloton, Chobani, and more on how brands earn their purpose
By Lydia BelangerOctober 13, 2021
Moderna vaccine
Health
Booster shots and a big jump in market value: 3 takeaways from Moderna’s Q2 earnings
By Sy MukherjeeAugust 5, 2021
A woman in an Allcyte lab coat looking at images of cancer cells on a screen.
Tech
British A.I. drug discovery startup Exscientia buys Austrian cancer cell screening company
By Jeremy KahnJune 15, 2021
Seniors face steep drug costs as Congress stalls on capping Medicare out-of-pockets
Health
Seniors face steep drug costs as Congress stalls on capping Medicare out-of-pockets
By Harris Meyer and Kaiser Health NewsDecember 28, 2020
Warren Buffett is going all in on the vaccine rally, piling into these stocks
Finance
Warren Buffett is going all in on the vaccine rally, piling into these stocks
By Katherine Chiglinsky and BloombergNovember 17, 2020
Key Speakers At The 2017 Milken Conference
Newsletters
Bristol Myers Squibb and Celgene got a beating in Congress on drug prices—but only Congress can fix the problem
By Sy MukherjeeOctober 1, 2020
Diversity is long overdue in the drug industry—and it’s going to take more than just hiring Black candidates
Health
Diversity is long overdue in the drug industry—and it’s going to take more than just hiring Black candidates
By Sy MukherjeeAugust 12, 2020
American Vasant Narasimhan, CEO of Swiss pharmaceutical and drug maker Novartis speaks during a conference at the Fortune Global Forum event in Paris on Nov. 18, 2019. (Photo by ERIC PIERMONT / AFP) (Photo by ERIC PIERMONT/AFP via Getty Images)
Newsletters
Healthcare is in the midst of a ‘paradigm shift’
By Katherine Dunn and Alan MurrayJuly 8, 2020
1
  • 1
  • 2
  • 3
3
Most Popular
Big Tech
As Big Tech showers employees with perks to win the talent war, Nvidia built a nearly $5 trillion company by making people pay for their own lunchplaceholder alt text
By Marco Quiroz-GutierrezJuly 1, 2026
Success
MacKenzie Scott alone accounted for one-third of America's $19.2 billion in megagifts last yearplaceholder alt text
By Sydney LakeJune 25, 2026
Newsletters
The Supreme Court's birthright citizenship ruling hands the U.S. economy a $7.7 trillion winplaceholder alt text
By Diane BradyJuly 1, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.